NCT05470543

Brief Summary

Breast cancer is the most common type of cancer in women with a high mortality rate in the world. Women may experience many different physiological and psychological symptoms (such as pain, nausea-vomiting, fatigue, stress, anger, and isolation) during diagnosis and treatment process. Family members often become caregivers at the time of diagnosis, and treatment of breast cancer patients. Therefore, family caregivers experience burden and poor health-related quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 18, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2022

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2023

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

8 months

First QC Date

July 19, 2022

Last Update Submit

January 16, 2023

Conditions

Keywords

Breast cancerCaregiver burdenWell-beingNurse-led care

Outcome Measures

Primary Outcomes (1)

  • Zarit Burden Interview (ZBI)

    The ZBI is a measure of caregiving burden developed by Zarit et al. (1980). The Turkish version of this scale has been validated by Inci and Erdem (2018). It consists of 22 items, and responses are recorded on a five-point Likert scale. The level of caregiver burden can be ascertained based on the total scale scores, which range from 0 to 88. Higher scores indicate a higher level of caregiver burden.The Cronbach's α of the Turkish version of this scale was 0.91 in Inci and Erdem (2018) validation study

    Change from baseline Zarit Burden Interview score at 9th weeks.

Secondary Outcomes (1)

  • Caregiver Well-Being Scale

    Change from baseline Caregiver Well-Being Scale score at 9th weeks.

Study Arms (2)

Nurse-led Supportive Care Group

EXPERIMENTAL
Behavioral: Nurse-led supportive care

Control Group

NO INTERVENTION

The control group received only usual care. They did not receive any intervention during the study period.

Interventions

Nurse-led supportive care was given to primary caregivers of women with breast cancer. Nurse-led supportive care was applied to primary caregivers for eight weeks in the form of face-to-face clinic interviews. It took an average of 30 minutes to interview with primary caregivers at the clinic.

Nurse-led Supportive Care Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being the primary caregiver of breast cancer patients
  • Literate
  • Able to understand and complete the questionnaires
  • Willingness to participate in the study

You may not qualify if:

  • Having communication problems
  • Having psychological diseases
  • Receiving any supportive care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bakircay University Faculty of Health Sciences

Izmir, 35560, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast NeoplasmsCaregiver Burden

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Pinar Zorba Bahceli, PhD

    Izmir Bakircay University Faculty of Health Sciences Izmir, Turkey, 35560

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 22, 2022

Study Start

April 18, 2022

Primary Completion

December 24, 2022

Study Completion

January 13, 2023

Last Updated

January 18, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations